Ellevest’s Standard BioTools LAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-30
Closed – – 1737
2022
Q2
$0 Sell
30
-8
-21% -$20 ﹤0.01% 1541
2022
Q1
$0 Buy
+38
New +$131 ﹤0.01% 1526
2021
Q2
– Sell
-10
Closed – – 1346
2021
Q1
$0 Hold
10
– – ﹤0.01% 1307
2020
Q4
$0 Buy
+10
New +$66 ﹤0.01% 1276

Other funds holding LAB

Ellevest's LAB Position: Q3 2022 in Review

Ellevest sold out of Standard BioTools (LAB) in Q3 2022, closing a stake of 30 shares.

Ellevest first reported a position in LAB in Q4 2020 and held it in 4 quarters. The position peaked at $0 in Q2 2022. 65 funds tracked by Wall St. Rank hold LAB as of Q3 2022.

  • Ellevest reported no remaining Standard BioTools position as of Q3 2022 after selling out during the quarter.
  • Ellevest sold 30 Standard BioTools shares in Q3 2022.
  • Ellevest first reported a position in Standard BioTools in Q4 2020 and held it in 4 quarters.
  • Ellevest's Standard BioTools position peaked at $0 in Q2 2022.
  • 65 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2022.

Based on Ellevest's 13F filing for Q3 2022, filed 2 Nov 2022.